Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Cornea and External Disease > Lipid-containing artificial tears better maintain corneal surface temperature
  • Cornea and External Disease

Lipid-containing artificial tears better maintain corneal surface temperature

Ophthalmology 360

Key Takeaways

  1. Lipid-deficient artificial tears were associated with a faster decline in corneal surface temperature during sustained eye opening.
  2. Lipid-containing artificial tears showed minimal changes in corneal surface temperature and better preserved thermal stability.
  3. The greatest temperature drop occurred within the first five seconds after blinking, particularly with lipid-deficient formulations.

Lipid-containing artificial tears maintained corneal surface temperature (CST) more effectively during sustained eye opening than lipid-deficient artificial tears, according to a study.

The study included 15 healthy volunteers between the ages of 20 to 40 examined under controlled environmental conditions. Each participant was tested on 4 hyaluronic acid–based artificial tears over separate visits, including 3 lipid-deficient products (Thealoz Duo and Artelac Advanced) and 2 lipid-containing products (Thealipid and Artelac Complete).

After drop instillation and acclimatization, participants were asked to keep their eyes open for 15 seconds while CST was measured in the central cornea using a high-sensitivity infrared camera. Results were compared with untreated contralateral eyes, with tear production and tear stability included in the analysis.

The lipid-deficient drops were associated with faster CST decline, with temperature slopes of −0.06 °C/15 s for Artelac Advanced and −0.12 °C/15 s for Thealoz Duo. In contrast, lipid-containing drops showed minimal CST changes, measured at 0.05 °C/15 s for Thealipid and −0.03 °C/15 s for Artelac Complete.

The largest temperature reductions occurred within the first 5 seconds after blinking, especially with lipid-deficient formulations. Tear production and tear break-up time did not significantly affect CST measurements.

Reference

Atalay E, Çalışkan ME, Aydın MT, et al. Corneal surface temperature dynamics with lipid vs non-lipid artificial tears during sustained eye opening: a crossover study. Cont Lens Anterior Eye. 2026 Jan 22;49(2):102623. doi: 10.1016/j.clae.2026.102623. Epub ahead of print. PMID: 41576856.

Share

Related Content

  • Cornea and External Disease

Quiz: The impact of blepharitis and conjunctivitis on quality of life

  • Cornea and External Disease

Phase 3 trial of cenegermin-bkbj for PCED enrolls first US patient

  • Cornea and External Disease

Cornea specialists identify key clinical signs linked to microbial keratitis subtypes

Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
  • Cornea and External Disease

Preventing complications of superficial keratectomy

  • Conference Roundup

Phase 1/2 CLARA study shows AURN001 improves BCVA compared with standard of care for corneal endothelial dysfunction

  • Conference Roundup

Epioxa crosslinking system has positive outcomes at 30 months in patients with keratoconus

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon